Did You Know

EASD: Novel DPP-4 Drug Works in Renal Impairment: The novel diabetes drug linagliptin (proposed trade name Ondero) may find a niche in treating patients with kidney problems. In a phase III study of patients who couldn’t take metformin because of the drug’s GI side effects or renal impairment, linagliptin effectively …

EASD: Lixisenatide Shows Potential: Lixisenatide monotherapy significantly improves glycemic control with a pronounced postprandial effect in patients with Type 2 diabetes, and is safe and well tolerated, according to a phase 3 trial. Lixisenatide is a new potent and selective once-daily GLP-1 receptor agonist in development for the treatment of …

Use of Diabetes Pills Up, Insulin Use Down: The proportion of Americans reporting treatment for diabetes who took oral medications to treat their condition increased from 60% in 1997 to 77% in 2007, a 28% increase, according to the latest “News and Numbers” from the Agency for Healthcare Research and …

Once-weekly Exenatide vs. Sitagliptin or Pioglitazone: Long-acting exenatide lowered glycosylated hemoglobin levels more than the other two drugs did. After 26 weeks, exenatide lowered the mean HbA1c level significantly more than either sitagliptin or pioglitazone (–1.5% vs. –0.9% and –1.2%). Patients who received exenatide also lost significantly more weight than …

Dietary Habits of African-Americans Are Similar, Diabetes or Not: African Americans are 1.8 times more likely to develop Type 2 diabetes and 1.4 times more likely to be obese than are non-Hispanic whites. Researchers looking for differences in the eating habits of African Americans based on whether or not they …

D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development: D-Tagatose, first in class, to treat diabetes could be the next new drug approved for diabetes and for the treatment of hypertriglyceridemia levels, pending results of the NEET trial. The effect on triglycerides is a secondary endpoint of the …

Ornish, Pritikin Cleared for Medicare Payment: Medicare will pay for intensive diet and exercise programs developed under the Ornish and Pritikin brands for reducing cardiovascular event risk, the Centers for Medicare and Medicaid Services announced.

Americans Don’t Know They’re Fat: Many Americans have skewed perceptions when it comes to their weight, often believing they are thinner than they really are, even when the scales are shouting otherwise, a new poll finds. As part of the survey, respondents were asked to provide their height and weight, …

Diabetes Incidence May Depend on Socioeconomic Status: It seems that women who make less money than their counterparts are more likely to develop Type 2 diabetes, Canadian researchers found in a new study. The study, which was conducted over a 14-year period from 1994 to 2008 by Statistics Canada, found …

Simple Solution to Preventing Risk for Diabetes: A change in diet may help reverse the growth in the number of people with Type 2 diabetes. While this number has grown significantly over the past twenty years, British researchers say one specific change may help. They reviewed several studies and discovered …